Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kengo Azushima

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Hypertension Reports|March 2, 2020
Recent Research Advances in Renin-Angiotensin-Aldosterone System ReceptorsKengo Azushima, Norihiko Morisawa, Kouichi Tamura, et al.
Nature Reviews. Nephrology|October 25, 2017
Modelling diabetic nephropathy in miceKengo Azushima, Susan B Gurley, Thomas M Coffman
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2021
ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyondKouichi Tamura, Kengo Azushima, Sho Kinguchi, et al.
Journal of the American Heart Association|April 17, 2023
Updates for Cardio-Kidney Protective Effects by Angiotensin Receptor-Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney ProtectionShunichiro Tsukamoto, Tatsuki Uehara, Kengo Azushima, et al.
American Journal of Hypertension|April 29, 2026
Tolvaptan Improves the Diurnal Blood Pressure Profile in Patients with Hypertension and Autosomal Dominant Polycystic Kidney DiseaseMasaaki Hanaoka, Hiromichi Wakui, Daisuke Kanai, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 17, 2025
Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysisYuichi Akasaki, Yasunori Suematsu, Kengo Azushima, et al.
Diabetes, Obesity & Metabolism|October 13, 2023
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitusShunichiro Tsukamoto, Shohei Tanaka, Takayuki Yamada, et al.
American Journal of Hypertension|March 10, 2025
Switching From ARBs to Sacubitril/Valsartan Safely Improves 24-Hour Ambulatory Blood Pressure in Patients With Advanced Chronic Kidney DiseaseSho Kinguchi, Kohei Ishiga, Hiromichi Wakui, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 26, 2023
Enhancement of angiotensin II type 1 receptor-associated protein in the paraventricular nucleus suppresses angiotensin II-dependent hypertensionMari Sotozawa, Sho Kinguchi, Hiromichi Wakui, et al.
Scientific Reports|May 14, 2021
Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patientsKazushi Uneda, Yuki Kawai, Takayuki Yamada, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Hypertension Reports|March 2, 2020
Recent Research Advances in Renin-Angiotensin-Aldosterone System ReceptorsKengo Azushima, Norihiko Morisawa, Kouichi Tamura, et al.
Nature Reviews. Nephrology|October 25, 2017
Modelling diabetic nephropathy in miceKengo Azushima, Susan B Gurley, Thomas M Coffman
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2021
ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyondKouichi Tamura, Kengo Azushima, Sho Kinguchi, et al.
Journal of the American Heart Association|April 17, 2023
Updates for Cardio-Kidney Protective Effects by Angiotensin Receptor-Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney ProtectionShunichiro Tsukamoto, Tatsuki Uehara, Kengo Azushima, et al.
American Journal of Hypertension|April 29, 2026
Tolvaptan Improves the Diurnal Blood Pressure Profile in Patients with Hypertension and Autosomal Dominant Polycystic Kidney DiseaseMasaaki Hanaoka, Hiromichi Wakui, Daisuke Kanai, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 17, 2025
Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysisYuichi Akasaki, Yasunori Suematsu, Kengo Azushima, et al.
Diabetes, Obesity & Metabolism|October 13, 2023
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitusShunichiro Tsukamoto, Shohei Tanaka, Takayuki Yamada, et al.
American Journal of Hypertension|March 10, 2025
Switching From ARBs to Sacubitril/Valsartan Safely Improves 24-Hour Ambulatory Blood Pressure in Patients With Advanced Chronic Kidney DiseaseSho Kinguchi, Kohei Ishiga, Hiromichi Wakui, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 26, 2023
Enhancement of angiotensin II type 1 receptor-associated protein in the paraventricular nucleus suppresses angiotensin II-dependent hypertensionMari Sotozawa, Sho Kinguchi, Hiromichi Wakui, et al.
Scientific Reports|May 14, 2021
Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patientsKazushi Uneda, Yuki Kawai, Takayuki Yamada, et al.
Pageof 10